The utility of quantitative 18F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer.
{"title":"The utility of quantitative <sup>18</sup>F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer.","authors":"Mai Hong Son, Nguyen Thi Phuong, Le Ngoc Ha","doi":"10.22038/aojnmb.2025.84029.1596","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study investigates the relationship between quantitative <sup>18</sup>F-FDG PET/CT metabolic parameters and overall survival (OS) in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC).</p><p><strong>Methods: </strong>We conducted a prospective analysis of 127 patients with RAI-R DTC. Quantitative metabolic parameters including SUV<sub>max</sub>, SUV<sub>mean</sub>, SUV<sub>peak</sub>, total metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were assessed in <sup>18</sup>F-FDG -avid recurrent or metastatic lesions via <sup>18</sup>F-FDG PET/CT imaging. Patients were monitored for disease progression and mortality for at least one-year post PET/CT imaging. Receiver operating characteristic (ROC) curves were used to establish cut-off values for predicting 5-year mortality, while the Kaplan-Meier method estimated the 5-year survival rate. Univariate and multivariate Cox regression analyses identified prognostic factors associated with OS.</p><p><strong>Results: </strong>The metabolic parameters derived from <sup>18</sup>F-FDG PET/CT demonstrated high sensitivity and specificity for predicting 5-year OS. ROC curve analysis established optimal cut-off values for SUV<sub>max</sub> (20.27 g/mL), SUV<sub>mean</sub> (7.46 g/mL), SUV<sub>peak</sub> (7.8 g/mL), TLG (45.74 g/mL×cm³), and MTV (5.78 cm<sup>3</sup>) (AUC: 0.82, 0.78, 0.82, 0.82, and 0.86, respectively; p<0.001). Kaplan-Meier analysis revealed significantly lower OS in patients with higher values of these parameters compared to those with lower ones (survival rates: 42.1% vs. 95.6%, 65.5% vs. 96%, 52.3% vs. 96.3%, 46.5% vs. 97.3%, and 57.3 % vs. 98.3%, respectively; p<0.001). Univariate Cox regression identified SUV<sub>max</sub>, SUV<sub>mean</sub>, SUV<sub>peak</sub>, TLG, and MTV as significant predictors of 5-year OS (p<0.05). In multivariate analysis, SUV<sub>peak</sub> and MTV emerged as independent predictors of OS.</p><p><strong>Conclusion: </strong>Quantitative <sup>18</sup>F-FDG PET/CT-derived parameters are significant predictors of 5-year OS, exhibiting high sensitivity and specificity. Elevated values of these parameters correlate with increased mortality rates. Our findings suggest that SUV<sub>peak</sub> and MTV are independent prognostic factors for 5-year OS in patients with radioiodine-refractory DTC.</p>","PeriodicalId":8503,"journal":{"name":"Asia Oceania Journal of Nuclear Medicine and Biology","volume":"13 2","pages":"156-165"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205131/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Oceania Journal of Nuclear Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22038/aojnmb.2025.84029.1596","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study investigates the relationship between quantitative 18F-FDG PET/CT metabolic parameters and overall survival (OS) in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC).
Methods: We conducted a prospective analysis of 127 patients with RAI-R DTC. Quantitative metabolic parameters including SUVmax, SUVmean, SUVpeak, total metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were assessed in 18F-FDG -avid recurrent or metastatic lesions via 18F-FDG PET/CT imaging. Patients were monitored for disease progression and mortality for at least one-year post PET/CT imaging. Receiver operating characteristic (ROC) curves were used to establish cut-off values for predicting 5-year mortality, while the Kaplan-Meier method estimated the 5-year survival rate. Univariate and multivariate Cox regression analyses identified prognostic factors associated with OS.
Results: The metabolic parameters derived from 18F-FDG PET/CT demonstrated high sensitivity and specificity for predicting 5-year OS. ROC curve analysis established optimal cut-off values for SUVmax (20.27 g/mL), SUVmean (7.46 g/mL), SUVpeak (7.8 g/mL), TLG (45.74 g/mL×cm³), and MTV (5.78 cm3) (AUC: 0.82, 0.78, 0.82, 0.82, and 0.86, respectively; p<0.001). Kaplan-Meier analysis revealed significantly lower OS in patients with higher values of these parameters compared to those with lower ones (survival rates: 42.1% vs. 95.6%, 65.5% vs. 96%, 52.3% vs. 96.3%, 46.5% vs. 97.3%, and 57.3 % vs. 98.3%, respectively; p<0.001). Univariate Cox regression identified SUVmax, SUVmean, SUVpeak, TLG, and MTV as significant predictors of 5-year OS (p<0.05). In multivariate analysis, SUVpeak and MTV emerged as independent predictors of OS.
Conclusion: Quantitative 18F-FDG PET/CT-derived parameters are significant predictors of 5-year OS, exhibiting high sensitivity and specificity. Elevated values of these parameters correlate with increased mortality rates. Our findings suggest that SUVpeak and MTV are independent prognostic factors for 5-year OS in patients with radioiodine-refractory DTC.